最新影響指數 - 實時趨勢預測 & 期刊影響力排名







One-click to visualize your research performance

One-click to visualize your research performance

One-click to visualize your research performance

One-click to visualize your research performance

Highly Cited Articles


High Impact Research Articles
Publication Title Author Listing
Publication Title Author Listing
· · · ·
· · · · · · · · · ·
· · ·
· · · · · · · · ·
· ·
· · ·
· · · · ·
· · · · · · · · · · · · ·
· · · · · · · · · · · · · · ·
· · · · · ·
· · · · · · · · ·
· · · · · · · ·
· · · · · · · ·
· ·
· · · · · ·
· · · · · · · ·
· · · · · · ·
· · · · ·
· · · · · ·
· · · · · ·
· · · · · · · · · · · · · · · · · ·
· · · · · · · ·
· · · · · · · · · ·
· · · ·
· · · · ·
· · · · · · · · ·
· · · · · · · · ·
· · · · · · · · · · · ·
· · · · · · · · · · ·
· · ·
· · ·
· · · · ·
· · · · · · · · · · · · ·
· ·
· · · · · · ·
· ·
· · · · ·
· · · · · · · · · ·
· · · · · ·
· · · · · · ·
· · · · · · ·
· ·
· · · · · · · · · ·
· · · · · · ·
· · · ·
· · · ·
· · · ·
· · · · · ·
· · · ·

Highly Cited Keywords


High Impact Research Keywords




Pancreas 2020-2021 年的影響指數為3.327。

Pancreas Impact Factor
最高影響指數 IF


最低影響指數 IF


影響指數 累積成長率
影響指數 累積成長率


影響指數 平均成長率
影響指數 平均成長率



子領域 四分位數 排名 百分比
Internal Medicine Q2 44/121

Internal Medicine 64%

Endocrinology, Diabetes and Metabolism Q2 93/219

Endocrinology, Diabetes and Metabolism 57%

Hepatology Q3 32/62

Hepatology 49%

Endocrinology Q3 63/117

Endocrinology 46%


· 在Internal Medicine研究領域,Pancreas的四分位數為Q2。Pancreas在Internal Medicine研究類別的121種相關期刊中排名第44。在Internal Medicine研究領域,Pancreas的排名百分位約為64%。
· 在Endocrinology, Diabetes and Metabolism研究領域,Pancreas的四分位數為Q2。Pancreas在Endocrinology, Diabetes and Metabolism研究類別的219種相關期刊中排名第93。在Endocrinology, Diabetes and Metabolism研究領域,Pancreas的排名百分位約為57%。
· 在Hepatology研究領域,Pancreas的四分位數為Q3。Pancreas在Hepatology研究類別的62種相關期刊中排名第32。在Hepatology研究領域,Pancreas的排名百分位約為49%。
· 在Endocrinology研究領域,Pancreas的四分位數為Q3。Pancreas在Endocrinology研究類別的117種相關期刊中排名第63。在Endocrinology研究領域,Pancreas的排名百分位約為46%。

Pancreas Impact Factor 2022 Prediction

Pancreas Impact Factor Predition System

Pancreas Impact Factor Prediction System is now online. You can start share your valuable insights with the community.

Predict Check All Preditions






2020-2021 3.327
2019-2020 2.92
2018-2019 2.675
2017-2018 2.958
2016-2017 2.967
2015-2016 2.738
2014-2015 2.959
2013-2014 3.008
2012-2013 2.953
2011-2012 2.386

· Pancreas 2020-2021年的影響指數為3.327
· Pancreas 2019-2020年的影響指數為2.92
· Pancreas 2018-2019年的影響指數為2.675
· Pancreas 2017-2018年的影響指數為2.958
· Pancreas 2016-2017年的影響指數為2.967
· Pancreas 2015-2016年的影響指數為2.738
· Pancreas 2014-2015年的影響指數為2.959
· Pancreas 2013-2014年的影響指數為3.008
· Pancreas 2012-2013年的影響指數為2.953
· Pancreas 2011-2012年的影響指數為2.386


出版數量 引用數量
出版数量 引用数量
1986 81 18
1987 111 63
1988 117 194
1989 105 339
1990 107 566
1991 116 601
1992 113 676
1993 118 815
1994 120 881
1995 133 960
1996 138 939
1997 135 1273
1998 159 1658
1999 130 2182
2000 137 2278
2001 135 2552
2002 149 2771
2003 189 3348
2004 309 3640
2005 331 4315
2006 395 4801
2007 390 5816
2008 406 6089
2009 314 6455
2010 295 6894
2011 254 7082
2012 232 8591
2013 217 9205
2014 249 10090
2015 189 10241
2016 265 9781
2017 272 9743
2018 215 7292
2019 245 7988
2020 267 9667
2021 25 727

· Pancreas於1986年發表了81篇报告,並取得18篇文獻引用。
· Pancreas於1987年發表了111篇报告,並取得63篇文獻引用。
· Pancreas於1988年發表了117篇报告,並取得194篇文獻引用。
· Pancreas於1989年發表了105篇报告,並取得339篇文獻引用。
· Pancreas於1990年發表了107篇报告,並取得566篇文獻引用。
· Pancreas於1991年發表了116篇报告,並取得601篇文獻引用。
· Pancreas於1992年發表了113篇报告,並取得676篇文獻引用。
· Pancreas於1993年發表了118篇报告,並取得815篇文獻引用。
· Pancreas於1994年發表了120篇报告,並取得881篇文獻引用。
· Pancreas於1995年發表了133篇报告,並取得960篇文獻引用。
· Pancreas於1996年發表了138篇报告,並取得939篇文獻引用。
· Pancreas於1997年發表了135篇报告,並取得1273篇文獻引用。
· Pancreas於1998年發表了159篇报告,並取得1658篇文獻引用。
· Pancreas於1999年發表了130篇报告,並取得2182篇文獻引用。
· Pancreas於2000年發表了137篇报告,並取得2278篇文獻引用。
· Pancreas於2001年發表了135篇报告,並取得2552篇文獻引用。
· Pancreas於2002年發表了149篇报告,並取得2771篇文獻引用。
· Pancreas於2003年發表了189篇报告,並取得3348篇文獻引用。
· Pancreas於2004年發表了309篇报告,並取得3640篇文獻引用。
· Pancreas於2005年發表了331篇报告,並取得4315篇文獻引用。
· Pancreas於2006年發表了395篇报告,並取得4801篇文獻引用。
· Pancreas於2007年發表了390篇报告,並取得5816篇文獻引用。
· Pancreas於2008年發表了406篇报告,並取得6089篇文獻引用。
· Pancreas於2009年發表了314篇报告,並取得6455篇文獻引用。
· Pancreas於2010年發表了295篇报告,並取得6894篇文獻引用。
· Pancreas於2011年發表了254篇报告,並取得7082篇文獻引用。
· Pancreas於2012年發表了232篇报告,並取得8591篇文獻引用。
· Pancreas於2013年發表了217篇报告,並取得9205篇文獻引用。
· Pancreas於2014年發表了249篇报告,並取得10090篇文獻引用。
· Pancreas於2015年發表了189篇报告,並取得10241篇文獻引用。
· Pancreas於2016年發表了265篇报告,並取得9781篇文獻引用。
· Pancreas於2017年發表了272篇报告,並取得9743篇文獻引用。
· Pancreas於2018年發表了215篇报告,並取得7292篇文獻引用。
· Pancreas於2019年發表了245篇报告,並取得7988篇文獻引用。
· Pancreas於2020年發表了267篇报告,並取得9667篇文獻引用。
· Pancreas於2021年發表了25篇报告,並取得727篇文獻引用。
· Pancreas的總出版物為7163。
· Pancreas的總引用數為150531。

Pancreas | Academic Accelerator - About the Journal


Pancreas provides a central forum for communication of original works involving both basic and clinical research on the exocrine and endocrine pancreas and their interrelationships and consequences in disease states. This multidisciplinary, international journal covers the whole spectrum of basic sciences, etiology, prevention, pathophysiology, diagnosis, and surgical and medical management of pancreatic diseases, including cancer. Features Include: Original articles covering new basic and clinical research Reviews Case Reports Letters to the Editor. None


Pancreas的ISSN是 0885-3177 ISSN是一個8位數的代碼,用於識別各種報紙,期刊,雜誌和期刊以及所有媒體 - 包括印刷版和電子版。

ISSN (Online)
ISSN (Online)

Pancreas的ISSN(Online)是 1536-4828 . ISSN是一個8位數的代碼,用於識別各種報紙,期刊,雜誌和期刊以及所有媒體 - 包括印刷版和電子版。

Lippincott Williams and Wilkins Ltd.

Pancreas的出版社是 Lippincott Williams and Wilkins Ltd.


Pancreas publishes reports Bimonthly .

1986 - Present

Pancreas的出版年度包含 1986 - Present .




The language of Pancreas is English .

United States

The publisher of Pancreas is Lippincott Williams and Wilkins Ltd. , which locates in United States .

What is Impact Factor?

The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly average number of citations of articles published in the last two years in a given journal. It is frequently used as a proxy for the relative importance of a journal within its field; journals with higher impact factor values are often deemed to be more important, or carry more intrinsic prestige in their respective fields, than those with lower values.

Pancreas | Academic Accelerator - About the Impact Factor

Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Impact Factor of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Impact Factor are often deemed to be more important than those with lower ones. The Pancreas Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Pancreas during the two preceding years (2018-2019). Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New journals, which are indexed from their first published issue, will receive an impact factor after two years of indexing; in this case, the citations to the year prior to Volume 1, and the number of articles published in the year prior to Volume 1, are known zero values. Journals that are indexed starting with a volume other than the first volume will not get an impact factor until they have been indexed for three years. Occasionally, Journal Citation Reports assigns an impact factor to new journals with less than two years of indexing, based on partial citation data. The calculation always uses two complete and known years of item counts, but for new titles one of the known counts is zero. Annuals and other irregular publications sometimes publish no items in a particular year, affecting the count. The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Pancreas.


The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI). Impact factors are calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson ISI was sold to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


The impact factor is used to compare different journals within a certain field. The Web of Science indexes more than 11,500 science and social science journals. Journal impact factors are often used to evaluate the merit of individual articles and individual researchers. This use of impact factors was summarised by Hoeffel:

Impact Factor is not a perfect tool to measure the quality of articles but there is nothing better and it has the advantage of already being in existence and is, therefore, a good technique for scientific evaluation. Experience has shown that in each specialty the best journals are those in which it is most difficult to have an article accepted, and these are the journals that have a high impact factor. Most of these journals existed long before the impact factor was devised. The use of impact factor as a measure of quality is widespread because it fits well with the opinion we have in each field of the best journals in our specialty....In conclusion, prestigious journals publish papers of high level. Therefore, their impact factor is high, and not the contrary.

Eugene Garfield

In brief, Impact factors may be used by:
  • Authors to decide where to submit an article for publication.
  • Libraries to make collection development decisions
  • Academic departments to assess academic productivity
  • Academic departments to make decisions on promotion and tenure.
As impact factors are a journal-level metric, rather than an article- or individual-level metric, this use is controversial. Garfield agrees with Hoeffel,but warns about the "misuse in evaluating individuals" because there is "a wide variation [of citations] from article to article within a single journal". Other things to consider about Impact Factors:
  • Many journals do not have an impact factor.
  • The impact factor cannot assess the quality of individual articles. Even if citations were evenly distributed among articles, the impact factor would only measure the interests of other researchers in an article, not its importance and usefulness.
  • Only research articles, technical notes and reviews are “citable” items. Editorials, letters, news items and meeting abstracts are “non-citable items”.
  • Only a small percentage of articles are highly cited and they are found in a small subset of journals. This small proportion accounts for a large percentage of citations.
  • Controversial papers, such as those based on fraudulent data, may be highly cited, distorting the impact factor of a journal.
  • Citation bias may exist. For example, English language resources may be favoured. Authors may cite their own work.
Moreover, informed and careful use of these impact data is essential, and should be based on a thorough understanding of the methodology used to generate impact factors. There are controversial aspects of using impact factors:
  • It is not clear whether the number of times a paper is cited measures its actual quality.
  • Some databases that calculate impact factors fail to incorporate publications including textbooks, handbooks and reference books.
  • Certain disciplines have low numbers of journals and usage. Therefore, one should only compare journals or researchers within the same discipline.
  • Review articles normally are cited more often and therefore can skew results.
  • Self-citing may also skew results.
  • Some resources used to calculate impact factors have inadequate international coverage.
  • Editorial policies can artificially inflate an impact factor.
Impact factors have often been used in advancement and tenure decision-making. Many recognize that this is a coarse tool for such important decisions, and that a multitude of factors should be taken into account in these deliberations. When considering the use of the impact factor (IF), keep these aspects in mind:
  • IF analysis is limited to citations from the journals indexed by the Web of Science/Web of Knowledge. Currently, the Web of Science indexes only 8621 journals across the full breadth of the sciences, and just 3121 in the social sciences.
  • A high IF/citation rate says nothing about the quality -- or even, validity -- of the references being cited. Notorious or even retracted articles often attract a lot of attention, hence a high number of citations. The notority related to the first publication on "cold fusion" is one such example.
  • Journals that publish more "review articles" are often found near the top of the rankings. While not known for publishing new, creative findings, these individual articles tend to be heavily cited.
  • The IF measures the average number of citations to articles in the journal -- given this, a small number of highly-cited articles will skew the figure.
  • It takes several years for new journals to be added to the list of titles indexed by the Web of Science/Web of Knowledge, so these newer titles will be under-represented.
  • It's alleged that journal editors have learned to "game" the system, encouraging authors to cite their works previously published in the same journal.
Comparing Journals Across Disciplines? Not a good idea! Using Impact Factors within a given discipline should only be done with great care, as described above. Using impact factor data to compare journals across disciplines is even more problematic. Here are some of the reasons:
  • Disciplines where older literature is still referenced, such as Chemistry and Mathematics, offer challenges to the methodolgy since older citations (older than two years) are not used to calculate the impact factor for a given journal. (Five-year impact factor analysis, which can be calculated using the Journal Citation Index database, helps smooth out this problem only to some degree.)
  • Different disciplines have different practices regarding tendency to cite larger numbers of references. Higher overall citation rates will bump upward impact factor measurements.
  • Where it's common for large numbers of authors to collaborate on a single paper, such as in Physics, the tendency of authors to cite themselves (and in this case, more authors) will result in increased citation rates.

Pros and Cons of the Impact Factor


  • A vetted, established metric for measuring journal impact within a discipline.
  • Designed to eliminate bias based on journal size and frequency.
  • Individual articles makes an uneven contribution to overall Impact Factor.
  • Impact Factor does not account for certain things, things like context (postive or negative citaion) and intentionality (self-citation).
  • The metric is proprietary to and bound by the contents of the Thomson Reuters database.
  • Citations, on which the Impact Factor is based, count for less than 1% of an article's overall use.


Numerous critiques have been made regarding the use of impact factors. A 2007 study noted that the most fundamental flaw is that impact factors present the mean of data that are not normally distributed, and suggested that it would be more appropriate to present the median of these data. There is also a more general debate on the validity of the impact factor as a measure of journal importance and the effect of policies that editors may adopt to boost their impact factor (perhaps to the detriment of readers and writers). Other criticism focuses on the effect of the impact factor on behavior of scholars, editors and other stakeholders. Others have made more general criticisms, arguing that emphasis on impact factor results from negative influence of neoliberal policies on academia claiming that what is needed is not just replacement of the impact factor with more sophisticated metrics for science publications but also discussion on the social value of research assessment and the growing precariousness of scientific careers in higher education.
Experts stress that there are limitations in using impact factors to evaluate a scholar's work. There are many reasons cited for not relying on impact factor alone to evaluate the output of a particular individual. Among these are the following:

  • A single factor is not sufficient for evaluating an author's work.
  • Journal values are meaningless unless compared within the same discipline. Impact factors vary among disciplines.
  • The impact factor was originally devised to show the impact of a specific journal, not a specific scholar. The quality and impact of the author's work may extend beyond the impact of a particular journal.
According to Jim Testa, a researcher for ThomsonReuters Scientific, the most widespread misuse of the Impact Factor is to evaluate the work of an individual author (instead of a journal). "To say that because a researcher is publishing in a certain journal, he or she is more influential or deserves more credit is not necessarily true. There are many other variables to consider." (interview 6/26/2008 in Thomson Reuters blog entry)


影響指數(IF)經常用作表明期刊對其領域重要性的指標。它是由科學信息研究所的創始人Eugene Garfield首次提出的。儘管IF被機構和臨床醫生廣泛使用,但是人們對於IF日記的計算方法,其意義以及如何利用它存在著廣泛的誤解。期刊的影響指數與同行評議過程的質量和期刊的內容質量等因素無關,而是一種反映對期刊,書籍,論文,項目報告,報紙上發表的文章的平均引用次數的度量,會議/研討會論文集,在互聯網上發布的文件,說明以及任何其他批准的文件。

Pancreas | Academic Accelerator - About the Impact Factor

影響指數通常用於評估期刊在其領域內的相對重要性,以及衡量期刊在特定時間段內引用“平均文章”的頻率。發表更多評論文章的期刊將獲得最高的IF。 IF較高的期刊被認為比IF較低的期刊更重要。根據尤金·加菲爾德(Eugene Garfield)的說法,“影響只是反映期刊和編輯吸引最佳論文的能力。”發表更多評論文章的期刊將獲得最大的IF。

In addition to functional dyspepsia, 35% of dyspepsia is unresolved dyspepsia, which is a symptom of the early stage of pancreatic exocrine insufficiency in the abdomen.

The Importance of Enzyme Substitution Therapy in Early Pancreas Exocrines of Insufficiency [10.17140/goj-4-131]

In this study, 15 commercial acidic drugs have been evaluated for pancreatic lipase (PL) inhibitory activity using an in vitro spectrophotometric method.

Evaluation of selected commercial pharmacotherapeutic drugs as potential pancreatic lipase inhibitors and antiproliferative compounds [10.1002/ddr.21499]

Therefore the aim of the present study was to examine the effects of potent GPR55 agonists, O-1602 and abnormal cannabidiol (Abn-CBD), on glucose-induced insulin secretion in a mouse pancreatic β-cell line, MIN6, and the underlying mechanisms with a focus on intracellular calcium (Ca2+).

G-protein coupled receptor 55 agonists increase insulin secretion through inositol trisphosphate-mediated calcium release in pancreatic β-cells. [10.1016/j.ejphar.2019.04.050]

Indication for pancreaticoscopy was suspected malignancy within the strictures associated with chronic pancreatitis, for cholangiopancreaticoscopy – assessment of spread of major duodenal papilla tumor into common bile and pancreatic ducts.

Первые результаты применения новой технологии визуальной оценки и лечения заболеваний билиарного тракта и протоков поджелудочной железы [10.16931/1995-5464.20192105-116]

A 61-year-old Japanese man with IgG4-related autoimmune pancreatitis developed a mass in the right atrium (RA) and a mass lesion surrounding the left anterior descending coronary artery.

IgG4-related Disease Involving the Cardiovascular System: An Intracardiac Mass and a Mass Lesion Surrounding a Coronary Artery [10.2169/internalmedicine.2509-18]

In particular, the redefinition of necrotizing pancreatitis offers a new understanding of this disease.

MR imaging for acute pancreatitis: the current status of clinical applications. [10.21037/ATM.2019.05.37]

Objective: To assess the effectiveness and safety of therapeutic ultrasound with sham ultrasound on pain relief and functional improvement in knee osteoarthritis patients.

Effects of therapeutic ultrasound for knee osteoarthritis: a systematic review and meta-analysis [10.1177/0269215519866494]

Methods A pilot study to test 3 educational strategies for caregivers of pediatric intensive care unit patients.

Post‐Intensive Care Syndrome: Educational Interventions for Parents of Hospitalized Children [10.4037/ajcc2019151]

A rare variant of this type of lymphoma is found in immunocompromised patients specifically in the gastrointestinal tract with accompanying gastrointestinal symptoms.

Burkitt Lymphoma of the Duodenum: An Uncommon Phenomenon [10.1155/2019/7313706]

The patients were divided into two cohorts: those receiving treatment at academic cancer centers (ACCs) and those receiving treatment at community cancer centers (CCCs).

Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy [10.1245/s10434-019-07843-5]

Resume L’arrivee des therapies ciblees cytostatiques, ainsi que les strategies medico-chirurgicales actuelles, ont bouleverse la prise en charge des cancers colorectaux metastatiques (CCRm), pour lesquels l’utilisation de scores pronostiques et predictifs guidant les strategies est un enjeu de recherche majeur.

Mesure de la réponse radiologique scannographique des cancers colorectaux métastatiques : état des lieux et perspectives [10.1016/j.bulcan.2019.08.013]

For further investigation, in vivo cancer radiotherapy was carried out by using female BALB/c mice with 4T1 breast tumors.

Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging. [10.1088/1361-6560/ab2154]

Acute subdural hematoma (ASDH) revealing mycotic aneurysm (MA) is an exceptional occurrence.

Mycotic intracranial aneurysms rupture presenting as pure acute subdural hematoma in infectious endocarditis. Report of 2 cases and review of the literature [10.1016/j.jocn.2018.12.035]

Although revascularisation in non-ST-segment elevation acute coronary syndrome (NSTEACS) is associated with better outcomes, its impact in older adult patients is unclear.

Revascularisation in older adult patients with non-ST-segment elevation acute coronary syndrome: effect and impact on 6-month mortality [10.1177/2048872619849922]

Conclusion Early CT may be used in patients visiting hospital with suspected acute biliary pancreatitis to facilitate urgent treatment.

Utility of Early CT in Patients with Suspected Acute Biliary Pancreatitis [10.3348/jksr.2019.80.4.704]

There was no significant difference in the prevalence of Helicobacter pylori between the case group and the control group in esophageal adenocarcinoma (8.

Systematic Review with Meta-analysis: Association of Helicobacter pylori Infection with Esophageal Cancer [10.1155/2019/1953497]

According to these findings, the mass was diagnosed as a basal cell adenocarcinoma.

Basal cell adenocarcinoma on bulbar conjunctiva of third eyelid in a dog [10.1292/jvms.18-0369]

He underwent a TaTME with diverting ileostomy due to a low rectal adenocarcinoma on December 2017.

Delayed presentation of rectourethral fistula following TaTME (transanal total mesorectal excision) [10.1007/s10151-019-02046-2]

The present study aimed to clarify the mechanism underlying abnormal CD146 expression in human pulmonary large cell neuroendocrine carcinoma (LCNEC) cell lines (NCI-H460 and NCI-H810).

CD146 promotes migration and proliferation in pulmonary large cell neuroendocrine carcinoma cell lines [10.3892/ol.2018.9830]

dCPD is widely expressed throughout the nervous system, including peptidergic neurons in the mushroom body and neuroendocrine cells expressing adipokinetic hormone.

Drosophila carboxypeptidase D (SILVER) is a key enzyme in neuropeptide processing required to maintain locomotor activity levels and survival rate [10.1101/551853]

e15693Background: Resection of the primary tumor in metastatic neuroendocrine tumor (NET) is controversial.

Role of resection of the primary in metastatic well/intermediate-differentiated neuroendocrine tumor (NET). [10.1200/JCO.2019.37.15_SUPPL.E15693]

Background: Pineal gland tumors range from the well-differentiated “pineocytoma” [World Health Organization (WHO) grade I], which have a very good prognosis, to the aggressive and poorly differentiated “pineoblastoma” (WHO grade IV) with “pineal parenchymal tumor of intermediate differentiation” (PPTID; WHO grades II and III) occupying intermediary differentiation and prognosis.

Primary pineal tumors – Unraveling histological challenges and certain clinical myths [10.4103/0028-3886.258045]

38Background: Adequate tissue acquisition is important in making treatment decisions for patients with upper gastrointestinal subepithelial tumors (SETs).

Prospective comparative study of endoscopic ultrasonography-guided fine-needle biopsy and unroofing biopsy. [10.1200/JCO.2019.37.4_SUPPL.38]

Fluorescence in situ hybridization using custom probes flanking PGR and NR4A3 genes was applied to 17 epithelioid leiomyosarcomas, 6 endometrial stromal tumors, and 3 perivascular epithelioid cell tumors.

PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features [10.1097/PAS.0000000000001239]

The oxytocin receptor is located in various brain regions, including the sensory information‐processing cerebral cortex; the cognitive information‐processing prefrontal cortex; reward‐related regions such as the ventral tegmental areas, nucleus accumbens and raphe nucleus; stress‐related areas such as the amygdala, hippocampus, ventrolateral part of the ventromedial hypothalamus and ventrolateral periaqueductal gray; homeostasis‐controlling hypothalamus; and the dorsal motor complex controlling intestinal functions.

Role of oxytocin in the control of stress and food intake [10.1111/jne.12700]

A 50-year-old woman was recently admitted to our nuclear medicine department for sentinel node scintigraphy before surgery on a right breast ductal carcinoma.

Grade 3 anaphylactic shock after administration of [99mTc]-labeled nanocolloidal albumin (Nanocoll®) for sentinel node scintigraphy [10.1007/s00259-019-04311-w]

Mammary carcinoma with osteoclast-like giant cell is a very rare subtype of invasive ductal carcinoma not otherwise specified of the WHO classification of Breast tumors.

Mammary carcinoma with osteoclast‐like giant cell: Fine needle aspiration and cytological diagnosis of a rare and misleading subtype of invasive ductal carcinoma [10.1111/cyt.12669]

3-resistant cells isolated from the phage-carrier-state cultures contained a mutation inactivating the two-component regulatory system ArlRS, essential for efficient expression of numerous S.

The Ability of Lytic Staphylococcal Podovirus vB_SauP_phiAGO1.3 to Coexist in Equilibrium With Its Host Facilitates the Selection of Host Mutants of Attenuated Virulence but Does Not Preclude the Phage Antistaphylococcal Activity in a Nematode Infection Model [10.3389/fmicb.2018.03227]

In this study, we show that the B cell–specific loss of GRK2 severely disrupts B cell trafficking and immune cell homeostasis.

Biased S1PR1 Signaling in B Cells Subverts Responses to Homeostatic Chemokines, Severely Disorganizing Lymphoid Organ Architecture [10.4049/jimmunol.1900678]

Here, we show that epigenetic silencing of NDRG4 modulates integrin signaling by assembling β1-integrins into large punctate clusters at the leading edge of tumor cells to promote an “adhesive switch,” decreasing cell adhesion to fibronectin and increasing cell adhesion and migration towards vitronectin, an important component of human lymph nodes.

NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients [10.1038/s41523-019-0106-x]